Dar Zavain's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 2,924 Class A Common Stock done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals ... | Dar Zavain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 2,924 | 135,817 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 44,031 | 44,031 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 22,016 | 132,893 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 2,745 | 110,877 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,907 | 108,132 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 2,229 | 106,225 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 1,843 | 103,996 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 26,193 | 26,193 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 13,097 | 102,153 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 1,467 | 89,056 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Dar Zavain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,393 | 55,216 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Dar Zavain | Director | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 14 Dec 2023 | 20,141 | 53,823 | - | 9 | 181,269 | Class A Common Stock |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,863 | 72,044 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 25,224 | 25,224 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 12,612 | 70,181 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 1,996 | 57,569 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2022 | 2,420 | 20,565 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 36,290 | 36,290 | - | - | Stock Option (right to buy) | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,145 | 18,145 | - | 0 | Class A Common Stock | |
| Recursion Pharmaceuticals ... | Zavain Dar | Director | Other type of transaction at price $ 0.00 per share. | 07 Dec 2021 | 3,599 | 3,599 | - | 0 | Class A common stock |